Anti-inflammatory activity of antifungal preparations.

Author(s): Rosen T, Schell BJ, Orengo I

Affiliation(s): Department of Dermatology, Baylor College of Medicine, Houston, Texas, USA.

Publication date & source: 1997-10, Int J Dermatol., 36(10):788-92.

Publication type: Clinical Trial; Randomized Controlled Trial

BACKGROUND: Although steroid/antifungal combination medications are used extensively, they are associated with potential disadvantages. Antifungal preparations possessing inherent anti-inflammatory activity, leading to rapid symptomatic relief while providing mycologic cure, would be very useful. OBJECTIVE: Our purpose was to investigate the anti-inflammatory activity of proprietary antifungal preparations in an in vivo, human experimental model. METHODS: Using a double-blind, controlled protocol, we assessed the comparative ability of antifungal preparations to suppress the expected delayed erythema response following in vivo human exposure to ultraviolet B (UVB) irradiation generated by a solar stimulator. RESULTS: Currently available allylamine preparations and ciclopirox olamine proved to be the most anti-inflammatory, while ketoconazole was intermediate in anti-inflammatory activity under these experimental conditions. These agents were superior to oxiconazole, econazole, and 2.5% hydrocortisone. CONCLUSIONS: Some antifungal preparations possess inherent anti-inflammatory activity, although the exact mechanism remains uncertain.